default author photo

Mario Poljak

University of Ljubljana - Institute of Microbiology and Immunology

Slovenia

SCHOLARLY PAPERS

3

DOWNLOADS

225

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Human Papillomavirus Negative High Grade Cervical Lesions and Cancers: Suggested Guidance for Hpv Testing Quality Assurance

Number of pages: 38 Posted: 27 Sep 2023
University of Besançon - French National Papillomavirus Reference Center, Karolinska Institutet, Karolinska University Hospital - Swedish National HPV Reference Laboratory, Royal Infirmary of Edinburgh - Scottish HPV Reference Laboratory, Instituto Nacional de Enfermedades Infecciosas-ANLIS "Dr Malbrán" - Laboratorio Nacional y Regional de Referencia de Papilomavirus Humanos, Instituto Nacional de Enfermedades Infecciosas-ANLIS "Dr Malbrán" - Laboratorio Nacional y Regional de Referencia de Papilomavirus Humanos, Instituto Nacional de Enfermedades Infecciosas-ANLIS "Dr Malbrán" - Laboratorio Nacional y Regional de Referencia de Papilomavirus Humanos, The Royal Women’s Hospital - Centre for Women’s Infectious Diseases Research, University of Melbourne - Department of Obstetrics and Gynaecology, Instituto Nacional de Cancerología - Subdirección de Investigación, Sciensano - National Reference Centre for Human Papillomaviruses, Viral Diseases, Infectious Diseases in Human, National Influenza Centre, Algemeen Medisch Laboratorium - National Reference Centre for Human Papillomaviruses, Algemeen Medisch Laboratorium - National Reference Centre for Human Papillomaviruses, Ghent University - National Reference Centre for Human Papillomaviruses, Laboratory of Medical Microbiology, Scientific Institute of Public Health - Unit of Cancer Epidemiology, University of Besançon - French National Papillomavirus Reference Center, University of Besançon - French National Papillomavirus Reference Center, University of Cologne - Institute of Virology, Akershus University Hospital - Norwegian HPV Reference Laboratory, Akershus University Hospital - Norwegian HPV Reference Laboratory, University of Ljubljana - Institute of Microbiology and Immunology, Karolinska Institutet, Karolinska University Hospital - Swedish National HPV Reference Laboratory, Karolinska Institutet, Karolinska University Hospital - Swedish National HPV Reference Laboratory, Karolinska Institutet, Karolinska University Hospital - Swedish National HPV Reference Laboratory, Government of the United States of America - Division of High Consequence Pathogens and Pathology, Government of the United States of America - Division of High Consequence Pathogens and Pathology, Government of the United States of America - Division of High Consequence Pathogens and Pathology and Karolinska Institutet, Karolinska University Hospital - Swedish National HPV Reference Laboratory
Downloads 103 (674,591)

Abstract:

Loading...

human papillomavirus, HSIL, Cervical Cancer, quality assurance, HPV testing, screening

2.

Optimizing Anal High-Grade Squamous Intraepithelial Lesions Screening Strategies Using HPV DNA and E6/E7 mRNA Detection in Men Who Have Sex with Men Living with HIV

Number of pages: 19 Posted: 25 Sep 2023
Bellvitge University Hospital, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Carlos III Health Institute, Bellvitge University Hospital, Bellvitge University Hospital, Bellvitge University Hospital, Gran Via de l'Hospitale, National Institutes of Health, ISGlobal, Bellvitge University Hospital, Bellvitge University Hospital, University of Ljubljana - Institute of Microbiology and Immunology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Bellvitge University Hospital, Bellvitge University Hospital and Bellvitge University Hospital - Department of Internal Medicine and Infectious Diseases
Downloads 62 (942,565)

Abstract:

Loading...

anal cancer screening, HSIL, HPV, High resolution anoscopy, viral biomarkers

3.

IPVS Policy Statement on HPV Nucleic Acid Testing Guidance for Those Utilising/Considering HPV as Primary Precancer Screening: Quality Assurance and Quality Control Issues

Number of pages: 26 Posted: 03 Aug 2022
The Royal Women’s Hospital - Centre for Women’s Infectious Diseases Research, University of Tübingen - Institute for Medical Virology and Epidemiology of Viral Diseases, Royal Infirmary of Edinburgh - Scottish HPV Reference Laboratory, Charité - Universitätsmedizin Berlin, Scientific Institute of Public Health - Unit of Cancer Epidemiology, National Institutes of Health, ISGlobal, University of Ljubljana - Institute of Microbiology and Immunology, Karolinska Institutet - Department of Laboratory Medicine, Government of the United States of America - Division of High Consequence Pathogens and Pathology, University of Cambridge - Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, University of Malaya (UM), All India Institute of Medical Sciences (AIIMS), The University of Hong Kong - Queen Mary Hospital, University of California San Francisco, University of South Florida - Morsani College of Medicine, Australian Centre for the Prevention of Cervical Cancer and Harvard University - Brigham and Women’s Hospital
Downloads 60 (961,006)

Abstract:

Loading...

HPV, primary, cervical, screening, validation